Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions
RSC Advances · 2024 · 14 (39) · 28889-28903
DOI: 10.1039/d4ra05462h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Heba T Abdel-Mohsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki P.O. 12…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Technology Development Fund.
Abstract (Originalsprache)
A series of new benzimidazole–dioxo(benzo)isoindoline conjugates were designed and synthesized as dual VEGFR-2 and FGFR-1 inhibitors. Compound 8m demonstrated potent % inhibition of 80.69% and 76.83% on VEGFR-2 and FGFR-1 at 10 μM, respectively.
Autor:innen und Institutionen
- Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki P.O. 12622 Cairo Egypt hebabdelmohsen@gmail.com ht.abdel-mohsen@nrc.sci.eg.
- High Throughput Molecular and Genetic Technology Lab, Center of Excellence for Advanced Sciences, Biochemistry Department, Biotechnology Research Institute, National Research Centre Dokki P.O. 12622 Cairo Egypt.
ORCID-Profile: Heba T Abdel-Mohsen
Förderung
- Science and Technology Development Fund
Zitieren
APA
Abdel-Mohsen, H. T., & Nageeb, A. M. (2024). Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions. RSC Advances, 14(39), 28889-28903. https://doi.org/10.1039/d4ra05462h
Vancouver
Abdel-Mohsen HT, Nageeb AM. Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions. RSC Advances. 2024;14(39):28889-28903. doi:10.1039/d4ra05462h
BibTeX
@article{AbdelMohsen2024,
author = {Abdel-Mohsen, Heba T and Nageeb, Amira M},
title = {Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {39},
pages = {28889--28903},
doi = {10.1039/d4ra05462h}
}
EUVIMED